Winter deals - Siste sjanse!

Winter deals - Siste sjanse!

Fri frakt over 399 kr
Fri frakt over 399 kr
Kundeservice
Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

1 490 kr

1 490 kr

På lager

On., 22 jan. - ti., 28 jan.


Sikker betaling

14 dagers åpent kjøp


Selges og leveres av

Adlibris


Produktbeskrivelse

This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include-but are not limited to-Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.

Artikkel nr.

5e0e8bc3-16ee-4fdb-907d-23669e099ebe

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

1 490 kr

1 490 kr

På lager

On., 22 jan. - ti., 28 jan.


Sikker betaling

14 dagers åpent kjøp


Selges og leveres av

Adlibris